These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24872690)

  • 1. Nanometer-scale siRNA carriers incorporating peptidomimetic oligomers: physical characterization and biological activity.
    Konca YU; Kirshenbaum K; Zuckermann RN
    Int J Nanomedicine; 2014; 9():2271-85. PubMed ID: 24872690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.
    Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H
    Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
    Sato Y; Matsui H; Sato R; Harashima H
    J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of kinesin spindle protein targeting siRNA in solid lipid nanoparticles to cellular models of tumor vasculature.
    Ying B; Campbell RB
    Biochem Biophys Res Commun; 2014 Apr; 446(2):441-7. PubMed ID: 24607899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.
    Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J
    Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary study of a novel transfection modality for in vivo siRNA delivery to vocal fold fibroblasts.
    Kraja I; Bing R; Hiwatashi N; Rousseau B; Nalband D; Kirshenbaum K; Branski RC
    Laryngoscope; 2017 Jul; 127(7):E231-E237. PubMed ID: 27996099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
    Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
    J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells.
    Khare P; Dave KM; Kamte YS; Manoharan MA; O'Donnell LA; Manickam DS
    AAPS J; 2021 Dec; 24(1):8. PubMed ID: 34873640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptidomimetic siRNA transfection reagent for highly effective gene silencing.
    Utku Y; Dehan E; Ouerfelli O; Piano F; Zuckermann RN; Pagano M; Kirshenbaum K
    Mol Biosyst; 2006 Jun; 2(6-7):312-7. PubMed ID: 16880950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of the physicochemical properties and potency of siRNA-loaded small-sized lipid nanoparticles for siRNA delivery.
    Sato Y; Note Y; Maeki M; Kaji N; Baba Y; Tokeshi M; Harashima H
    J Control Release; 2016 May; 229():48-57. PubMed ID: 26995758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation.
    Kubota K; Onishi K; Sawaki K; Li T; Mitsuoka K; Sato T; Takeoka S
    Int J Nanomedicine; 2017; 12():5121-5133. PubMed ID: 28790820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
    Ma D
    Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies.
    Fernandes JC; Qiu X; Winnik FM; Benderdour M; Zhang X; Dai K; Shi Q
    Int J Nanomedicine; 2012; 7():5833-45. PubMed ID: 23209368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
    Cheng X; Lee RJ
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum albumin-coated lipid nanoparticles for delivery of siRNA to breast cancer.
    Piao L; Li H; Teng L; Yung BC; Sugimoto Y; Brueggemeier RW; Lee RJ
    Nanomedicine; 2013 Jan; 9(1):122-9. PubMed ID: 22542825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
    Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
    ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface coating of siRNA-peptidomimetic nano-self-assemblies with anionic lipid bilayers: enhanced gene silencing and reduced adverse effects in vitro.
    Zeng X; de Groot AM; Sijts AJ; Broere F; Oude Blenke E; Colombo S; van Eden W; Franzyk H; Nielsen HM; Foged C
    Nanoscale; 2015 Dec; 7(46):19687-98. PubMed ID: 26553270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene silencing by gold nanoshell-mediated delivery and laser-triggered release of antisense oligonucleotide and siRNA.
    Huschka R; Barhoumi A; Liu Q; Roth JA; Ji L; Halas NJ
    ACS Nano; 2012 Sep; 6(9):7681-91. PubMed ID: 22862291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.